Press Release Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights Jul 30
Press Release Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Jul 16
Press Release Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants Jul 14
Press Release Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants Jul 14